Zusammenfassung
Die Implantation der Blastozyste ist ein komplexer Prozess, auf den der Embryo und das Endometrium zum korrekten Zeitpunkt vorbereitet sein müssen. Die Implantation des menschlichen Embryos lässt sich aus ethischen Gründen in vivo kaum untersuchen. Erkenntnisse aus Tiermodellen sind aufgrund deutlicher speziesbezogener Unterschiede nur sehr eingeschränkt übertragbar. Aus diesen Gründen werden zunehmend 3‑dimensionale Modelle entwickelt, in denen Trophoblastsphäroide oder embryoide Strukturen mit einer deziduaähnlichen Matrix konfrontiert werden. Im vorliegenden Beitrag werden die aktuell bekannten Faktoren und Interaktionen mit Bedeutung für die Implantation zusammengefasst, sowohl auf zellulärer als auch auf molekularer Ebene. Zunächst werden vorbereitende Prozesse im Menstruationszyklus beschrieben. Daran schließt sich eine Beschreibung relevanter Komponenten des Immunsystems an, wobei ausführlich auf die Eigenschaften und Funktionen uteriner natürlicher Killerzellen eingegangen wird. Im Weiteren wird die Rolle verschiedener molekularer Faktoren in der Implantation diskutiert (Zytokine, Wachstumsfaktoren, Zelladhäsionsmoleküle, Hormone). Perspektivisch ist damit zu rechnen, dass Studien an den oben erwähnten 3‑dimensionalen Modellen trotz aller Limitationen neue Erkenntnisse zur Embryoimplantation beim Menschen liefern werden. Dies könnte sich letztlich positiv auf die reproduktionsmedizinische Praxis auswirken.
Abstract
The implantation of the blastocyst is a complex process for which the embryo and the endometrium must be prepared at the correct point in time. For ethical reasons it is nearly impossible to investigate the implantation of human embryos in vivo. Due to clear species-related differences the transfer of knowledge from animal models is very limited. For these reasons 3‑dimensional models are increasingly being developed in which spheroid trophoblast or embryoid structures are confronted with a decidua-like matrix. This article summarizes the currently known factors and interactions, which are important for implantation at both the cellular and also the molecular levels. At first the preparatory processes in the menstrual cycle are described. This is followed by a description of relevant components of the immune system, whereby the properties and functions of uterine natural killer cells are dealt with in detail. Furthermore, the role of various molecular factors in the implantation is discussed (cytokines, growth factors, cell adhesion molecules, hormones). In perspective, it is to be expected that despite all the limitations studies on the abovementioned 3‑dimensional models will provide new knowledge on human embryo implantation. This could ultimately have a positive effect on the practice of reproductive medicine.
Literatur
Fitzgerald JS et al (2008) Trophoblast invasion: the role of intracellular cytokine signalling via signal transducer and activator of transcription 3 (STAT3). Hum Reprod Update 14(4):335–344
Kammerer U, von Wolff M, Markert UR (2004) Immunology of human endometrium. Immunobiology 209(7):569–574
Herrler A, von Rango U, Beier HM (2003) Embryo-maternal signalling: how the embryo starts talking to its mother to accomplish implantation. Reprod Biomed Online 6(2):244–256
Reed BG, Carr BR (2000) The normal menstrual cycle and the control of ovulation. In: Feingold KR et al (Hrsg) Endotext
Thiyagarajan DK, Basit H, Jeanmonod R (2024) Physiology, menstrual cycle. StatPearls, Treasure Island (FL)
Banchereau J et al (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18(1):767–811
Bulmer JN, Johnson PM (1984) Macrophage populations in the human placenta and amniochorion. Clin Exp Immunol 57(2):393–403
Heikkinen J et al (2003) Phenotypic characterization of human decidual macrophages. Clin Exp Immunol 131(3):498–505
Wegmann TG et al (1993) Bidirectional cytokine interactions in the maternal-fetal relationship: is successful pregnancy a TH2 phenomenon? Immunol Today 14(7):353–356
Bulmer JN, Williams PJ, Lash GE (2010) Immune cells in the placental bed. Int J Dev Biol 54(2):281–294
Wienke J et al (2020) Human tregs at the materno-fetal interface show site-specific adaptation reminiscent of tumor tregs. JCI Insight. https://doi.org/10.1172/jci.insight.137926
Svensson-Arvelund J et al (2015) The human fetal placenta promotes tolerance against the semiallogeneic fetus by inducing regulatory T cells and homeostatic M2 macrophages. J Immunol 194(4):1534–1544
Starkey PM, Clover LM, Rees MCP (1991) Variation during the menstrual cycle of immune cell populations in human endometrium. Eur J Obstet Gynecol Reprod Biol 39(3):203–207
Russell P et al (2013) The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. III: further observations and reference ranges. Pathology 45(4):393–401
Colucci F, Di Santo JP, Leibson PJ (2002) Natural killer cell activation in mice and men: different triggers for similar weapons? Nat Immunol 3:807
Moffett-King A (2002) Natural killer cells and pregnancy. Nat Rev Immunol 2:656
Marron K, Walsh D, Harrity C (2018) Detailed endometrial immune assessment of both normal and adverse reproductive outcome populations. J Assist Reprod Genet. https://doi.org/10.1007/s10815-018-1300-8
Bulmer JN, Lash GE (2005) Human uterine natural killer cells: a reappraisal. Mol Immunol 42(4):511–521
Zhang J, Croy BA, Tian Z (2005) Uterine natural killer cells: their choices, their missions. Cell Mol Immunol 2(2):123–129
Lanier LL et al (1986) The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes. J Immunol 136(12):4480–4486
Chiokadze M et al (2020) Beyond uterine natural killer cell numbers in unexplained recurrent pregnancy loss: combined analysis of CD45, CD56, CD16, CD57, and CD138. Diagnostics. https://doi.org/10.3390/diagnostics10090650
Croy BA et al (2003) Uterine natural killer cells: insights into their cellular and molecular biology from mouse modelling. Reproduction 126(2):149–160
Smith SD et al (2009) Evidence for immune cell involvement in decidual spiral arteriole remodeling in early human pregnancy. Am J Pathol 174(5):1959–1971
Gong X et al (2014) Insights into the paracrine effects of uterine natural killer cells. Mol Med Rep 10(6):2851–2860
El-Azzamy H et al (2018) Dysregulated uterine natural killer cells and vascular remodeling in women with recurrent pregnancy losses. Am J Reprod Immunol 80(4):e13024
Poehlmann TG et al (2006) Inhibition of term decidual NK cell cytotoxicity by soluble HLA-G1. Am J Reprod Immunol 56(5–6):275–285
Chaouat G et al (2005) Cytokines and implantation. Chem Immunol Allergy 88:34–63
Bachmayer N et al (2006) Aberrant uterine natural killer (NK)-cell expression and altered placental and serum levels of the NK-cell promoting cytokine interleukin-12 in pre-eclampsia. Am J Reprod Immunol 56(5):292–301
Dosiou C, Giudice LC (2005) Natural killer cells in pregnancy and recurrent pregnancy loss: endocrine and immunologic perspectives. Endocr Rev 26(1):44–62
Kofod L, Lindhard A, Hviid TVF (2018) Implications of uterine NK cells and regulatory T cells in the endometrium of infertile women. Hum Immunol 79(9):693–701
Kuon RJ et al (2017) Uterine natural killer cells in patients with idiopathic recurrent miscarriage. Am J Reprod Immunol. https://doi.org/10.1111/aji.12721
Quenby S et al (2009) Uterine natural killer cells and angiogenesis in recurrent reproductive failure. Hum Reprod 24(1):45–54
Tuckerman E et al (2010) Uterine natural killer cells in peri-implantation endometrium from women with repeated implantation failure after IVF. J Reprod Immunol 87(1–2):60–66
Zhu L et al (2018) Increased natural killer cell subsets with inhibitory cytokines and inhibitory surface receptors in patients with recurrent miscarriage and decreased or normal subsets in kidney transplant recipients late post-transplant. Clin Exp Immunol 193(2):241–254
Sharkey AM, Smith SK (2003) The endometrium as a cause of implantation failure. Best Pract Res Clin Obstet Gynaecol 17(2):289–307
Tabibzadeh S, Babaknia A (1995) The signals and molecular pathways involved in implantation, a symbiotic interaction between blastocyst and endometrium involving adhesion and tissue invasion. Hum Reprod 10(6):1579–1602
Godbole G et al (2017) Decrease in expression of HOXA10 in the decidua after embryo implantation promotes trophoblast invasion. Endocrinology 158(8):2618–2633
Salamonsen LA et al (2016) The microenvironment of human implantation: determinant of reproductive success. Am J Reprod Immunol 75(3):218–225
Burton GJ et al (2002) Uterine glands provide histiotrophic nutrition for the human fetus during the first trimester of pregnancy. J Clin Endocrinol Metab 87(6):2954–2959
Chaouat G, Ledee-Bataille N, Dubanchet S (2005) Immunological similarities between implantation and pre-eclampsia. Am J Reprod Immunol 53(5):222–229
Markert UR, Morales-Prieto DM, Fitzgerald JS (2011) Understanding the link between the IL‑6 cytokine family and pregnancy: implications for future therapeutics. Expert Rev Clin Immunol 7(5):603–609
Dimitriadis E et al (2005) Cytokines, chemokines and growth factors in endometrium related to implantation. Hum Reprod Update 11(6):613–630
Guzeloglu-Kayisli O, Kayisli UA, Taylor HS (2009) The role of growth factors and cytokines during implantation: endocrine and paracrine interactions. Semin Reprod Med 27(1):62–79
Marwood M et al (2009) Interleukin-11 and leukemia inhibitory factor regulate the adhesion of endometrial epithelial cells: implications in fertility regulation. Endocrinology 150(6):2915–2923
Cullinan EB et al (1996) Leukemia inhibitory factor (LIF) and LIF receptor expression in human endometrium suggests a potential autocrine/paracrine function in regulating embryo implantation. Proc Natl Acad Sci U S A 93(7):3115–3120
Tangri S, Raghupathy R (1993) Expression of cytokines in placentas of mice undergoing immunologically mediated spontaneous fetal resorptions. Biol Reprod 49(4):850–856
Torchinsky A, Markert UR, Toder V (2005) TNF-alpha-mediated stress-induced early pregnancy loss: a possible role of leukemia inhibitory factor. Chem Immunol Allergy 89:62–71
Ashkar AA, Croy BA (2001) Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol 13(4):235–241
Mehta-Chimote B (2010) Cytokines and growth factors in implantation Bd. 1, S 219–243
Nose A, Takeichi M (1986) A novel cadherin cell adhesion molecule: its expression patterns associated with implantation and organogenesis of mouse embryos. J Cell Biol 103(6):2649–2658
Aplin JD (1997) Adhesion molecules in implantation. Rev Reprod 2(2):84–93
Lessey BA (2002) Adhesion molecules and implantation. J Reprod Immunol 55(1):101–112
Karizbodagh MP et al (2017) Implantation window and angiogenesis. J Cell Biochem 118(12):4141–4151
Cha J, Sun X, Dey SK (2012) Mechanisms of implantation: strategies for successful pregnancy. Nat Med 18(12):1754–1767
Simon C et al (2003) The role of estrogen in uterine receptivity and blastocyst implantation. Trends Endocrinol Metab 14(5):197–199
Psychoyos A, Nikas G, Gravanis A (1995) The role of prostaglandins in blastocyst implantation. Hum Reprod 10(2):30–42
Salleh N (2014) Diverse roles of prostaglandins in blastocyst implantation. ScientificWorldJournal 2014:968141
Paulson EE, Comizzoli P (2021) Endometrial receptivity and embryo implantation in carnivores-commonalities and differences with other mammalian species. Biol Reprod 104(4):771–783
Weber M et al (2021) Cytogenomics of six human trophoblastic cell lines. Placenta 103:72–75
Pastuschek J et al (2021) Molecular characteristics of established trophoblast-derived cell lines. Placenta 108:122–133
Zhang M, Reis AH, Simunovic M (2023) Human embryoids: a new strategy of recreating the first steps of embryonic development in vitro. Semin Cell Dev Biol 141:14–22
Ban Z, Knospel F, Schneider MR (2020) Shedding light into the black box: advances in in vitro systems for studying implantation. Dev Biol 463(1):1–10
Förderung
Das Placenta-Labor koordiniert das vom Bundesministerium für Bildung und Forschung (BMBF) geförderte Center for Early Pregnancy and Reproductive Health (CEPRE). U.R. Markert wird von der Deutschen Forschungsgemeinschaft gefördert (Projektnummer: 537607142).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Interessenkonflikt
M.T. Huber und U.R. Markert geben an, dass kein Interessenkonflikt besteht.
Für diesen Beitrag wurden von den Autor/-innen keine Studien an Menschen oder Tieren durchgeführt. Für die aufgeführten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.
Additional information
Redaktion
Georg Griesinger, Lübeck
Wolfgang Küpker, Baden-Baden
Hinweis des Verlags
Der Verlag bleibt in Hinblick auf geografische Zuordnungen und Gebietsbezeichnungen in veröffentlichten Karten und Institutsadressen neutral.
QR-Code scannen & Beitrag online lesen
Rights and permissions
About this article
Cite this article
Huber, M.T., Markert, U.R. Die Physiologie des Implantationsprozesses. Gynäkologische Endokrinologie 22, 95–101 (2024). https://doi.org/10.1007/s10304-024-00563-4
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10304-024-00563-4